华东医药：回购注销仅针对《2022年限制性股票激励计划》中的部分限制性股票

Group 1 - The company is currently repurchasing and canceling a portion of restricted stocks from the "2022 Restricted Stock Incentive Plan" [1] - Future plans regarding stock repurchase will be announced in accordance with information disclosure regulations [1]